BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38523303)

  • 1. [Inhibition of RANK ligand to treat bone metastases].
    Body JJ
    Bull Cancer; 2013 Nov; 100(11):1207-13. PubMed ID: 24158618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocalcaemia following denosumab in prostate cancer: A clinical review.
    Lau LH; Cliff ERS; Wong V; Wong H; Torkamani N; Eer A; Weickhardt A; Grossmann M
    Clin Endocrinol (Oxf); 2020 Jun; 92(6):495-502. PubMed ID: 32017154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent severe hypocalcemia following chemotherapy regimen changes in advanced breast cancer: two case reports.
    Yanase Y; Bando H; Sato R; Matsuo T; Ueda A; Okazaki M; Hashimoto S; Iguchi-Manaka A; Hara H
    J Med Case Rep; 2024 Mar; 18(1):150. PubMed ID: 38523303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
    Uhm SJ; Hall JA; Herrington JD
    J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(12):1819-1823. PubMed ID: 34853264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.
    Kinoshita Y; Arai M; Ito N; Takashi Y; Makita N; Nangaku M; Shinoda Y; Fukumoto S
    Endocr J; 2016 May; 63(5):479-84. PubMed ID: 26860123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases.
    Lechner B; DeAngelis C; Jamal N; Emmenegger U; Pulenzas N; Giotis A; Sheehan P; Tsao M; Bedard G; Chow E
    Support Care Cancer; 2014 Jul; 22(7):1765-71. PubMed ID: 24515277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.
    Nasser SM; Sahal A; Hamad A; Elazzazy S
    J Oncol Pharm Pract; 2019 Dec; 25(8):1846-1852. PubMed ID: 31694497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related hypercalcemia and potential treatments.
    Almuradova E; Cicin I
    Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management.
    Venetis K; Piciotti R; Sajjadi E; Invernizzi M; Morganti S; Criscitiello C; Fusco N
    Cells; 2021 Jun; 10(6):. PubMed ID: 34199522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocalcemia in cancer patients: An exploratory study.
    Ferraz Gonçalves JA; Costa T; Rema J; Pinto C; Magalhães M; Esperança A; Sousa L
    Porto Biomed J; 2019; 4(4):e45. PubMed ID: 31930179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy.
    Garla VV; Salim S; Kovvuru KR; Subauste A
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29982185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Thongprayoon C; Acharya P; Acharya C; Chenbhanich J; Bathini T; Boonpheng B; Sharma K; Wijarnpreecha K; Ungprasert P; Gonzalez Suarez ML; Cheungpasitporn W
    Osteoporos Int; 2018 Aug; 29(8):1737-1745. PubMed ID: 29713798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.
    Pittman K; Antill YC; Goldrick A; Goh J; de Boer RH
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):266-276. PubMed ID: 27862983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocalcaemia of malignancy.
    Schattner A; Dubin I; Huber R; Gelber M
    Neth J Med; 2016 Jul; 74(6):231-9. PubMed ID: 27571720
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.